Anthracyclines inhibit SARS-CoV-2 infection

Vaccines and drugs are two effective medical interventions to mitigate SARS-CoV-2 infection. Three SARS-CoV-2 inhibitors, remdesivir, paxlovid, and molnupiravir, have been approved for treating COVID-19 patients, but more are needed, because each drug has its limitation of usage and SARS-CoV-2 const...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhen, Pan, Qinghua, Ma, Ling, Zhao, Jianyuan, McIntosh, Fiona, Liu, Zhenlong, Ding, Shilei, Lin, Rongtuan, Cen, Shan, Finzi, Andrés, Liang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305762/
https://www.ncbi.nlm.nih.gov/pubmed/37379907
http://dx.doi.org/10.1016/j.virusres.2023.199164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305762/
https://www.ncbi.nlm.nih.gov/pubmed/37379907
http://dx.doi.org/10.1016/j.virusres.2023.199164

Ejemplares similares